We examined whether higher human papillomavirus type 16 (HPV16) viral load predicted risk of cervical intraepithelial neoplasia 3 (CIN3) or cancer (together termed ≥CIN3) within a cohort of 20,810 women followed for 10 years with cytologic screening. Semiquantitative viral load for HPV16 was measured on baseline cervicovaginal specimens using a type-specific hybridization probe test with signal amplification. An increased risk of ≥CIN3 associated with higher HPV16 viral load was found only among cytologically negative women in early follow-up, suggesting that these cases were related to the detection of prevalent lesions missed at baseline. Women with higher HPV16 viral load were more likely to undergo ablative treatment during follow-up than those with lower viral load (Ptrend = 0.008), possibly diminishing any additional risk for ≥CIN3 attributable to higher HPV16 viral loads. Copyright © 2005 American Association for Cancer Research.
CITATION STYLE
Castle, P. E., Schiffman, M., Scott, D. R., Sherman, M. E., Glass, A. G., Rush, B. B., … Lorincz, A. T. (2005). Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer. Cancer Epidemiology Biomarkers and Prevention, 14(5), 1311–1314. https://doi.org/10.1158/1055-9965.EPI-04-0799
Mendeley helps you to discover research relevant for your work.